Table 3.

Test of significance of variables in the multi-variable linear regression model.

Variable	Level	Mean % change in lesion size(95% CI)	p-value
Statins	Y	-0.7% (-2.8%, 1.5%)	<0.0001
	N	7.5% (5.4%, 9.6%)
CCB	Y	1.4% (-1.9%, 4.7%)	0.027
	N	5.3% (3.9%, 6.6%)
ASA	Y	3.9% (2.0%, 5.8%)	0.289
	N	2.8% (0.5%, 5.1%)
BB	Y	3.9% (1.8%, 5.9%)	0.270
	N	2.8% (0.6%, 5.0%)
ACEI	Y	3.3% (0.9%, 5.8%)	0.984
	N	3.3% (1.6%, 5.1%)
HLP	Y	3.4% (1.6%, 5.2%)	0.925
	N	3.3% (0.8%, 5.8%)

Estimates of relative mean change were computed for 1 year duration.

Abbreviations: CCB, calcium channel blocker; ASA, aspirin; BB, beta-blocker; ACEI, angiotensin converting enzyme inhibitors; HLP, hyperlipidemia.